Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction

A clear consensus does not exist about whether the initial dose of gemcitabine, an essential anticancer antimetabolite, should be reduced in patients with liver dysfunction. Adult patients with biliary tract or pancreatic cancer were divided into three groups according to whether they had mild, mode...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Sci
Main Authors: Shibata, Takashi, Ebata, Tomoki, Fujita, Ken‐ichi, Shimokata, Tomoya, Maeda, Osamu, Mitsuma, Ayako, Sasaki, Yasutsuna, Nagino, Masato, Ando, Yuichi
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2016
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768397/
https://ncbi.nlm.nih.gov/pubmed/26595259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12851
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker